Capricorn Fund Managers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
PDM
EAM
CA
Capricorn Fund Managers's ROIV Position: Q2 2026 in Review
Capricorn Fund Managers increased its Roivant Sciences (ROIV) stake by 101% in Q2 2026, buying an estimated $594K and bringing the position to 40,100 shares worth $1.42M. The position accounts for 0.11% of the portfolio, ranked #131.
Capricorn Fund Managers first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.67M in Q4 2025. 165 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Capricorn Fund Managers held 40,100 shares of Roivant Sciences worth $1.42M as of Q2 2026.
- Capricorn Fund Managers bought 20,100 Roivant Sciences shares in Q2 2026, an estimated $594K.
- Roivant Sciences made up 0.11% of Capricorn Fund Managers's portfolio in Q2 2026, its #131 holding.
- Capricorn Fund Managers first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
- Capricorn Fund Managers's Roivant Sciences position peaked at $9.67M in Q4 2025.
- 165 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.